AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+11.84%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.89B
AUM Growth
+$3.89B
(+0.38%)
Cap. Flow
-$658M
Cap. Flow
% of AUM
-16.88%
Top 10 Holdings %
Top 10 Hldgs %
78.03%
Holding
129
New
21
Increased
28
Reduced
28
Closed
19
Top Buys
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$96.7M |
| 2 |
Avidity Biosciences
RNA
|
$26.8M |
| 3 |
Cullinan Oncology
CGEM
|
$18.5M |
| 4 |
Merus
MRUS
|
$18.1M |
| 5 |
Vera Therapeutics
VERA
|
$14.8M |
Top Sells
| 1 |
CAVA Group
CAVA
|
$278M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$29.5M |
| 3 |
Viking Therapeutics
VKTX
|
$20.8M |
| 4 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$16.1M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$14.5M |
Sector Composition
| 1 | Consumer Discretionary | 56.42% |
| 2 | Healthcare | 42.2% |
| 3 | Technology | 0.99% |
| 4 | Financials | 0.15% |
| 5 | Consumer Staples | 0.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pinduoduo
PDD
$177B
| $6.05M | 0.15% |
45,500
-11,000
| -19% | -$1.46M |
|
52
NVIDIA
NVDA
$4.15T
| $5.31M | 0.14% |
43,000
+41,100
| +2,163% | +$2.96M |
|
53
Microsoft
MSFT
$3.76T
| $5.05M | 0.13% |
11,300
+8,800
| +352% | +$3.93M |
|
54
Visa
V
$681B
| $4.99M | 0.13% |
19,000
+16,500
| +660% | +$4.33M |
|
55
Black Diamond Therapeutics
BDTX
$164M
| $4.88M | 0.12% |
1,046,517
| – | – |
|
56
Dynatrace
DT
$15.1B
| $4.88M | 0.12% |
109,000
+73,000
| +203% | +$3.27M |
|
|
KLRS
57
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $4.77M | 0.12% |
6,597,167
| – | – |
|
58
Applied Therapeutics
APLT
$73.7M
| $4.71M | 0.12% |
1,009,500
| – | – |
|
59
TSMC
TSM
$1.2T
| $4.52M | 0.12% |
26,000
-6,000
| -19% | -$1.04M |
|
60
Foghorn Therapeutics
FHTX
$298M
| $4.14M | 0.11% |
720,720
| – | – |
|
61
Datadog
DDOG
$46.2B
| $3.75M | 0.1% |
28,925
+19,325
| +201% | +$2.51M |
|
62
Alto Neuroscience
ANRO
$97.7M
| $3.74M | 0.1% |
350,000
| – | – |
|
63
Amazon
AMZN
$2.41T
| $3.72M | 0.09% |
19,250
+7,250
| +60% | +$1.4M |
|
64
Fate Therapeutics
FATE
$115M
| $3.39M | 0.09% |
1,032,500
+672,189
| +187% | +$2.2M |
|
|
HOOK
65
DELISTED
HOOKIPA Pharma
HOOK
| $3.35M | 0.09% |
5,666,410
| – | – |
|
66
ADC Therapeutics
ADCT
$370M
| $3.22M | 0.08% |
+1,018,461
| New | +$3.22M |
|
67
KE Holdings
BEKE
$21.8B
| $3.18M | 0.08% |
225,000
-50,000
| -18% | -$708K |
|
68
Regenxbio
RGNX
$498M
| $2.93M | 0.07% |
250,000
| – | – |
|
|
OMGA
69
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.74M | 0.07% |
1,323,530
| – | – |
|
|
ELEV
70
DELISTED
Elevation Oncology
ELEV
| $2.74M | 0.07% |
1,013,015
-500,000
| -33% | -$1.35M |
|
71
Kenvue
KVUE
$39.2B
| $2.49M | 0.06% |
+137,000
| New | +$2.49M |
|
72
Sagimet Biosciences
SGMT
$239M
| $2.48M | 0.06% |
724,771
| – | – |
|
|
CBIO
73
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
| $2.42M | 0.06% |
8,589,064
| – | – |
|
74
Procore
PCOR
$10.3B
| $2.14M | 0.05% |
32,300
+22,800
| +240% | +$1.51M |
|
75
ServiceNow
NOW
$191B
| $1.97M | 0.05% |
+2,500
| New | +$1.97M |
|